A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in Healthy Adults

Clinical trial NCT07540910 · RECRUITING

Trial details

NCT number: NCT07540910
Sponsor: Enanta Pharmaceuticals, Inc
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Inducible Urticaria Chronic Spontaneous Urticaria

Start date: 2026-04-01
Primary completion: 2026-11-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.